Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Kiren Mitruka"'
Autor:
David B. Meya, Agnes N. Kiragga, Elizabeth Nalintya, Grace Banturaki, Joan Akullo, Phillip Kalyesubula, Patrick Sessazi, Hillary Bitakalamire, Joseph Kabanda, Julius N. Kalamya, Alice Namale, Moses Bateganya, Joseph Kagaayi, Steve Gutreuter, Michelle R. Adler, Kiren Mitruka
Publikováno v:
AIDS Research and Therapy, Vol 19, Iss 1, Pp 1-9 (2022)
Abstract Introduction Key and priority populations (with risk behaviours and health inequities) are disproportionately affected by HIV in Uganda. We evaluated the impact of an intensive case management intervention on HIV treatment outcomes in Kalang
Externí odkaz:
https://doaj.org/article/3da8df7059b04cd388912d38c9f38de2
Autor:
Leila Katirayi, Naemi Shoopala, Kiren Mitruka, Assegid Mengistu, Godfrey Woelk, Andrew L. Baughman, Gram Mutandi, Steven Y. Hong, Ndapewa Hamunime
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Namibia is a large sparsely populated country with a high prevalence of HIV. People living with HIV who reside in remote areas often travel long distances through tough desert terrain to access HIV care and treatment. To address t
Externí odkaz:
https://doaj.org/article/5c9de0a4915441f9beafa346b365359f
Autor:
Peter N Fonjungo, Shirley Lecher, Clement Zeh, Erin Rottinghaus, Helen Chun, Christiane Adje-Toure, Spencer Lloyd, Jane W Mwangi, Michael Mwasekaga, Yohannes Mengistu Eshete, Rituparna Pati, Tsietso Mots'oane, Kiren Mitruka, Anita Beukes, Christina Mwangi, Nancy Bowen, Ndapewa Hamunime, Rachel S Beard, Anyelwisye Kabuje, Susan Nabadda, Andrew F Auld, Shirish Balachandra, Innocent Zungu, James Kandulu, George Alemnji, Eboi Ehui, Heather Alexander, Dennis Ellenberger
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0282652 (2023)
IntroductionWe assessed progress in HIV viral load (VL) scale up across seven sub-Saharan African (SSA) countries and discussed challenges and strategies for improving VL coverage among patients on anti-retroviral therapy (ART).MethodsA retrospective
Externí odkaz:
https://doaj.org/article/69d713d963564b8face896f08fc8a80c
Autor:
Pamela J. Bachanas, Helen M. Chun, Neha Mehta, John Aberle‐Grasse, KaeAnne Parris, Michelle Williams Sherlock, Spencer Lloyd, Clement Zeh, Daphne K. Makwepa, Max L. Kapanda, Emily Kainne Dokubo, Leonard Bonono, Shirish Balachandra, Eboi Ehui, Peter Fonjungo, Aimé M. Nkoso, Sikhathele Mazibuko, Velephi N. Okello, Fana Tefera, Mirtie Getachew, Elizabeth M. Katiku, Andrew Mulwa, Fred M. Asiimwe, Tapiwa F. Tarumbiswa, Andrew F. Auld, Rose Nyirenda, Alzira P. Dos Santos De Louvado, Irenio Gaspar, Steven Y. Hong, Laimi Ashipala, Christopher Obanubi, Akudo Ikpeazu, Canisious Musoni, Emmanuel Yoboka, Simangele Mthethwa, Zukiswa Pinini, Sudhir Bunga, John Rumunu, Daniel J. Magesa, Beatrice Mutayoba, Lisa J. Nelson, Cordelia Katureebe, Simon Agolory, Lloyd B. Mulenga, Ponesai Nyika, Owen Mugurungi, Tedd Ellerbrock, Kiren Mitruka
Publikováno v:
Journal of the International AIDS Society, Vol 25, Iss 11, Pp n/a-n/a (2022)
Abstract Introduction The potential disruption in antiretroviral therapy (ART) services in Africa at the start of the COVID‐19 pandemic raised concern for increased morbidity and mortality among people living with HIV (PLHIV). We describe HIV treat
Externí odkaz:
https://doaj.org/article/484f371fd04b4e089b465f0fa1dc8333
Autor:
Seema T. Meloni, Oche Agbaji, Charlotte A. Chang, Patricia Agaba, Godwin Imade, Stephen Oguche, Ahmed Mukhtar, Kiren Mitruka, Mackenzie Hurlston Cox, Aaron Zee, Phyllis Kanki
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background The Joint United Nations Programme on HIV/AIDS 90–90-90 goal envisions 90% of all people receiving antiretroviral therapy to be virally suppressed by 2020. Implied in that goal is that viral load be quantified for all patients r
Externí odkaz:
https://doaj.org/article/5f2d946259414684b74f4537161071a2
Publikováno v:
Emerging Infectious Diseases, Vol 21, Iss 3, Pp 508-510 (2015)
A review of 26 tuberculosis outbreaks in the United States (2002–2011) showed that initial source case-patients had long infectious periods (median 10 months) and were characterized by substance abuse, incarceration, and homelessness. Improved time
Externí odkaz:
https://doaj.org/article/cf8c213cae984e2d8abff847acc4bcc4
Publikováno v:
Emerging Infectious Diseases, Vol 17, Iss 3, Pp 425-431 (2011)
To understand circumstances of tuberculosis transmission that strain public health resources, we systematically reviewed Centers for Disease Control and Prevention (CDC) staff reports of US outbreaks in which CDC participated during 2002–2008 that
Externí odkaz:
https://doaj.org/article/6486d296e6264e499177b3fddc2465d3
Autor:
Carla A. Winston, Kiren Mitruka
Publikováno v:
Emerging Infectious Diseases, Vol 18, Iss 7, Pp 1201-1202 (2012)
Externí odkaz:
https://doaj.org/article/273fa9c7976444af8c19065e816f92f6
Autor:
Beth Chaplin, Oche Agbaji, Harry Reyes Nieva, Bola Olatunde, Charlotte Chang, Kiren Mitruka, Halima Sule, Titus Dajel, Aaron Zee, Mukhtar L Ahmed, Isah Ahmed, Prosper Okonkwo, Holly Rawizza, Phyllis Kanki
Publikováno v:
Clinical Infectious Diseases. 76:e671-e680
BackgroundHuman immunodeficiency virus (HIV) viral load (VL) monitoring is critical for antiretroviral therapy (ART) management. Point-of-care (POC) VL testing has been reported to be feasible and preferred over standard-of-care (SOC) testing in many
Autor:
Charlotte Chang, Oche Agbaji, Kiren Mitruka, Bola Olatunde, Halima Sule, Titus Dajel, Aaron Zee, Mukhtar L Ahmed, Isah Ahmed, Prosper Okonkwo, Beth Chaplin, Phyllis Kanki
Publikováno v:
Clinical Infectious Diseases. 76:e681-e691
Background Point-of-care (POC) viral load (VL) tests provide results within hours, enabling same-day treatment interventions. We assessed treatment outcomes with POC vs standard-of-care (SOC) VL monitoring. Methods We implemented a randomized control